UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Mutual Advisors LLC

Mutual Advisors LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 6.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 20,835 shares of the healthcare conglomerate’s stock after purchasing an additional 1,346 shares during the quarter. Mutual Advisors LLC’s holdings in UnitedHealth Group were worth $11,685,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of UNH. Delta Financial Group Inc. grew its position in shares of UnitedHealth Group by 1.0% during the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after buying an additional 17 shares in the last quarter. Signature Resources Capital Management LLC grew its holdings in UnitedHealth Group by 40.0% during the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 18 shares in the last quarter. Saxony Capital Management LLC lifted its position in shares of UnitedHealth Group by 3.5% during the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after purchasing an additional 18 shares during the last quarter. GoalVest Advisory LLC increased its holdings in UnitedHealth Group by 0.6% in the second quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after buying an additional 18 shares during the last quarter. Finally, Fiduciary Group LLC lifted its holdings in UnitedHealth Group by 0.5% during the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after buying an additional 18 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Stephens reduced their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. TD Cowen lifted their price target on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Wells Fargo & Company raised their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Bank of America dropped their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Finally, Morgan Stanley dropped their target price on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $615.53.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $562.13 on Wednesday. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. The company has a 50-day moving average of $582.88 and a 200-day moving average of $540.32. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63. The firm has a market cap of $519.08 billion, a price-to-earnings ratio of 36.62, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the prior year, the firm earned $6.56 EPS. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.49%. UnitedHealth Group’s payout ratio is currently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.